LEVOTHYROXINE SODIUM
- Manufacturer
- DirectRX
- Effective date
- 2015-12-02
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:22:56
Label at a glance#
Label contents#
Full prescribing information#
Package Label
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LEVOTHYROXINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 97c252d3-9bb8-4530-bb44-9824dc7cf556 | Product name | 6 | 20250729 |
| 6c43b71c-35e6-4db3-ba24-c6ef42ff7003 | Product name | 3 | 20240207 |
| 890fd4bf-1a80-42b7-be1b-2d0259d5f0c8 | Product name | 5 | 20240207 |
| c8ad26bf-af73-460b-b74e-1eff16cc4f9f | Product name | 5 | 20240207 |
| 01383843-4069-43cf-aa76-dc17a6f9f8c4 | Product name | 2 | 20230123 |
| 978cca7d-a938-4791-8322-da48d90a63ef | Product name | 1 | 20230113 |
| 65f86ba3-8816-4e12-899b-18290c8de551 | Product name | 2 | 20210614 |
| f16ab90f-08c2-40be-a543-66d9827cd1f3 | Product name | 1 | 20210601 |
| 6a33ec05-2ae2-45e5-ab82-2d94b3303923 | Product name | 1 | 20190709 |
| 93355a10-1c44-4c92-a11d-7d995e0200d9 | Product name | 1 | 20190219 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-783-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b9b0-f424-e053-dadaa90a57ce | LEVOTHYROXINE SODIUM |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-783-30 | LEVOTHYROXINE SODIUM | 30 in 1 BOTTLE | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-783-30 | EA - Each | 61919-783 | e81a762b-837b-4115-a8c9-25bdf005006a | 1 | 2016-11-08 |
| 0527-1341-01 | EA - Each | 0527-1341 | 75066b2e-3f8d-4cc3-be90-8b5dc05d91c4 | 1 | 2012-07-24 |
| 0527-1341-10 | EA - Each | 0527-1341 | 9ca237f3-a3a9-417c-9ed9-247a72fecee1 | 1 | 2012-07-24 |
Products#
Every source-derived product name is available through these pages.
- LEVOTHYROXINE SODIUM
- ALUMINUM OXIDE
- LEVOTHYROXINE
- LACTOSE
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
- STARCH, CORN
- ACACIA
- FD&C YELLOW NO. 6
- SILICON DIOXIDE
- SODIUM STARCH GLYCOLATE TYPE A POTATO
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 61919-783 | 61919-783-30 |
| 0527-1341 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ALUMINUM OXIDE | LMI26O6933 | IACT |
| LEVOTHYROXINE SODIUM | 9J765S329G | ACTIR |
| LACTOSE | J2B2A4N98G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| ACACIA | 5C5403N26O | IACT |
| FD&C YELLOW NO. 6 | H77VEI93A8 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | 5856J3G2A2 | IACT |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021210-001 | UNITHROID | LEVOTHYROXINE SODIUM | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-002 | UNITHROID | LEVOTHYROXINE SODIUM | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-003 | UNITHROID | LEVOTHYROXINE SODIUM | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-004 | UNITHROID | LEVOTHYROXINE SODIUM | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-005 | UNITHROID | LEVOTHYROXINE SODIUM | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-006 | UNITHROID | LEVOTHYROXINE SODIUM | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-007 | UNITHROID | LEVOTHYROXINE SODIUM | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-008 | UNITHROID | LEVOTHYROXINE SODIUM | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-009 | UNITHROID | LEVOTHYROXINE SODIUM | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-010 | UNITHROID | LEVOTHYROXINE SODIUM | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 |
| N021210-011 | UNITHROID | LEVOTHYROXINE SODIUM | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 |
| N021210-012 | UNITHROID | LEVOTHYROXINE SODIUM | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021210-001 | AB1 |
| N021210-001 | AB2 |
| N021210-001 | AB3 |
| N021210-002 | AB1 |
| N021210-002 | AB2 |
| N021210-002 | AB3 |
| N021210-003 | AB1 |
| N021210-003 | AB2 |
| N021210-003 | AB3 |
| N021210-004 | AB1 |
| N021210-004 | AB2 |
| N021210-004 | AB3 |
| N021210-005 | AB1 |
| N021210-005 | AB2 |
| N021210-005 | AB3 |
| N021210-006 | AB1 |
| N021210-006 | AB2 |
| N021210-006 | AB3 |
| N021210-007 | AB1 |
| N021210-007 | AB2 |
| N021210-007 | AB3 |
| N021210-008 | AB1 |
| N021210-008 | AB2 |
| N021210-008 | AB3 |
| N021210-009 | AB1 |
| N021210-009 | AB2 |
| N021210-009 | AB3 |
| N021210-010 | AB1 |
| N021210-010 | AB2 |
| N021210-010 | AB3 |
| N021210-011 | AB1 |
| N021210-011 | AB2 |
| N021210-011 | AB3 |
| N021210-012 | AB1 |
| N021210-012 | AB2 |
| N021210-012 | AB3 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-005 | UNITHROID | 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-006 | UNITHROID | 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-007 | UNITHROID | 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-008 | UNITHROID | 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-009 | UNITHROID | 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-010 | UNITHROID | 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-011 | UNITHROID | 0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD, RS | 2000-08-21 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021210-012 | UNITHROID | 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2008-02-08 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-001 | UNITHROID | 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-002 | UNITHROID | 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-003 | UNITHROID | 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021210-004 | UNITHROID | 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET / ORAL | AB1,AB2,AB3 | RLD | 2000-08-21 | 31067a03dcf5… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-001 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-002 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-003 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-004 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-005 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-006 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-007 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-008 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-009 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-010 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-011 | AB3 | 3 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | AB2 | 2 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N021210-012 | AB3 | 3 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | AB2 | 2 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-001 | AB3 | 3 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N021210-002 | AB1 | 1 | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 25f013ed-a992-6173-e054-00144ff8d46c | 25f013ed-a991-6173-e054-00144ff8d46c | 2015-12-02 | Warnings, Adverse reactions | 25f013ed-a992-6173-e054-00144ff8d46c 25f013ed-a991-6173-e054-00144ff8d46c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
